A health headline might celebrate a lower inflammation marker or a younger-looking ageing score. It is reasonable to ask what changed. It is equally reasonable to ask whether anyone felt better, developed fewer illnesses or lived longer. Those are different outcomes, and a good article should tell you which was actually studied.

Markers are clues, not automatic guarantees

Biomarkers can help clinicians identify or monitor risk when their interpretation is established. Research biomarkers may be less mature. An intervention could change a marker without producing the hoped-for clinical benefit, or improve function without moving a particular marker. Laboratory precision alone does not establish that a test is useful for everyday decisions.

The CALERIE ageing analysis measured DNA methylation outcomes over two years. It was not a survival trial. By contrast, LIFE measured major mobility disability, an outcome directly relevant to independence. The questions and participants differed, so neither study should be used as a universal verdict on every healthy-ageing programme.

Read the result before the promise

Check whether the study's main outcome was specified in advance, whether the comparison group received support and how long participants were followed. Secondary analyses can be valuable but need careful interpretation. Relative changes also look larger than absolute differences. A claim about fewer illnesses should be backed by actual illness data.

  • Ask what the participants actually gained.
  • Look for a suitable comparison group.
  • Separate exploratory results from primary outcomes.
  • Treat lifespan promises as a particularly high evidence bar.

Zhen can help you work towards stronger movement, sustainable habits and an informed plan. We do not convert an improved body composition estimate or easier chair rise into a prediction of extra years. These changes deserve attention because of what they mean for life now.

Putting this into practice at Zhen

At Zhen Wellness in Onchan, Isle of Man, we help you turn health information into realistic next steps. The £97 Longevity MOT is a standalone 60-minute assessment of your history, priorities, posture, mobility and body composition estimates, with pain mapping where relevant. It is not a biological-age blood test, medical diagnosis or prediction of lifespan. Any further service is chosen separately around your needs, with costs discussed before you decide.

Research and safety

Sources checked on 14 October 2026. Studies describe their own participants and interventions, not Zhen treatment outcomes. Evidence can change; research is not free of bias. This article is general education, not individual medical advice. Adult fasting or exercise protocols are not suitable instructions for children. Seek appropriate clinical advice for new symptoms, medical conditions, pregnancy or treatment changes. Never stop prescribed medicines to follow a wellness plan.

Research references

  1. Waziry et al., Nature Aging (2023): CALERIE randomised trial, small biomarker effects and declared licensing interests
  2. Pahor et al., JAMA (2014): LIFE physical-activity trial and mobility disability

Explore support at Zhen Wellness

Ask Isabella about an appointment

Share this article

LinkedInFacebookWhatsApp